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Abstract
The most common type of stroke, i.e. ischemic stroke, is a great challenge for contemporary 
medicine as it poses both diagnostic and therapeutic difficulties. Atherosclerosis, which is 
rapidly beginning to affect more and more social groups, is the main cause of cerebrovascular 
accidents. Atherosclerosis is currently defined as a generalized, dynamic and heterogeneous 
inflammatory and immune process affecting arterial walls. Atherosclerotic plaque is the 
emanation of this disease. As the paradigm of the diagnosis of atherosclerosis has changed, 
it has become crucial to properly identify plaque instability within the carotid arteries by 
evaluating parameters and phenomena that signify a developing cascade of complications, 
eventually leading to stroke. Irrespective of the ultrasound technique employed, proper mor-
phological evaluation of atherosclerotic plaque, involving observation of its echogenicity, i.e. 
subjective analysis of its structure, with the classification to Gray-Weale–Nicolaides types as 
well as assessment of the integrity of its surface, makes it possible to roughly evaluate plaque 
morphology and thereby its stability. This enables treatment planning and therapy moni-
toring. This evaluation should be a prelude to further diagnostic work-up, which involves 
non-invasive examinations that enable unambiguous assessment of plaque stability. These 
examinations include contrast-enhanced ultrasound to assess progression or recession of 
inflammation, which presents as plaque neovascularization, or shear wave elastography to 













Poland, there are about 70,000 cases annually, 30,000 of 
which are fatal. A snowball increase is noted in the number 
of cerebrovascular accidents (CVAs), ranging from tran-
sient ischemic accidents (TIA) to ischemic strokes. This 
increase is estimated at 1.9% per year and is clearly linked 
with ageing society.
Atherosclerosis: a new paradigm in diagnosis
The fundamental and one of the main causes of CVAs is 
atherosclerosis, a disease which is beginning to affect 
more and more social groups. Atherosclerosis is currently 
defined as a generalized, dynamic and heterogeneous 
Introduction
Ischemic stroke, which is the most common type of stroke, 
is a great challenge for contemporary medicine. It poses 
both diagnostic and therapeutic difficulties. 
Advances in the treatment of ischemic strokes have offered 
patients a greater chance for recovery and return to nor-
mal life. That is why early diagnosis and identification of 
pathological conditions that might lead to this outcome are 
of particular importance.
Each year, 15 million cases of ischemic stroke are noted 
worldwide (214 cases per 100,000 inhabitants)(1). In 
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inflammatory and immune process that involves arterial 
walls. It may lead to blood flow obstruction in the affected 
vessel, which entails the occurrence of certain defined clin-
ical signs and symptoms. A structure called atherosclerotic 
plaque is central to the disorders induced by atherosclero-
sis(2) (Fig. 1). 
In accordance with the Mannheim consensus(3–6) published 
in 2007 and later revised, atherosclerotic plaque is defined 
as a focal structure that builds up into the arterial lumen 
to at least 0.5 mm or 50% of the surrounding intima-media 
thickness. The ability to evaluate plaque formation dynam-
ics and its complications (including rupture and displace-
ment) is a very important and not yet well-explored prob-
lem. Most patients with atherosclerotic plaque present no 
signs of vascular disorders, which means that most plaques 
are silent and asymptomatic.
Disorders do appear only with hemodynamically sig-
nificant stenosis or vascular occlusion and blood flow 
obstruction or blockage. These changes occur during the 
natural development of atherosclerosis that leads to the 
formation or development of changes within the plaque 
itself, such as its enlargement or mineral remodeling,(7) 
as well as changes within its lipid core and on its surface 
(so-called fibrous cap)(8).
In light of contemporary studies, the paradigm of the 
relationship of atherosclerosis and CVAs has changed 
as there are also plaques of vast damage potential that 
do not cause vascular stenoses or occlusion by their 
sole presence, but since they are capable of initiating 
a cascade leading to the formation and activation of 
plaque-related clots, they may cause ischemic strokes 
that in consequence result in sudden death(9). Owing 
to this potential, these plaques are called unstable or 
“vulnerable”(10,11). 
The main problem in atherosclerotic plaque imaging is to 
identify the moment of potential transformation of a stable 
plaque into vulnerable plaque. The identification of a precise 
time of plaque destabilization defines the moment of proper 
treatment initiation, whether it be conservative treatment 
(anti-aggregation therapy, statins, cilostazol and other phos-
phodiesterase 3 inhibitors, peroxisome proliferator-activated 
receptors (PPAR) and their agonists, metalloproteinase 
inhibitors) or a surgical procedure (endarterectomy, endo-
vascular procedures and sonothrombolysis or ultrasound-
accelerated thrombolysis enhanced with contrast agents).
Vulnerable plaque as a diagnostic target
In patients at risk of cerebral ischemia, a site that is both cru-
cial for the build-up of pathologic changes and convenient 
for clinical assessment is the carotid artery, a vessel repre-
sentative for the evaluation of atherosclerosis progression.
The detection of features indicating active inflammation 
within atherosclerotic plaque, based on neovascularization 
within the lipid core structures or monitoring the levels of 
inflammatory products, is a criterion of certain atheroscle-
rotic plaque instability(12,13).
Definition of vulnerable plaque
The density of neovascular network within atherosclerotic 
plaque correlates with the stage of atherosclerosis(14). These 
vessels are believed to be the primary cause of complica-
tions in the development of atherosclerotic plaque as they 
are a site of bleeding or inflammation and may in conse-
quence lead to the loss of plaque stability. The degree of 
their “maturity” is proportional to a decrease in plaque sta-
bility as they are more susceptible to damage, and there-
fore also to blood extravasation to the plaque, formation of 
microthrombi and abrupt plaque enlargement(15,16).
The plaque transforms from stable plaque into plaque with 
thin fibrous cap atheroma/thin cap atheromatic plaque, 
(TFCA/TCAP) and finally into unstable or vulnerable 
plaque(11,17) (Fig. 2).
In the case of fibrous cap rupture, when the lipid core is 
damaged and there is potential bleeding into the plaque, 
the material is released into the vascular lumen, which 
might lead to vascular occlusion and a CVA(16,18).
It is then currently crucial to properly identify plaque insta-
bility within the carotid arteries by evaluating parameters 
and phenomena that signify an initiating cascade of com-
plications eventually leading to stroke.
The evaluation of atherosclerotic plaque should then include:
• fibrous cap thickness;
• size of the lipid necrotic core;
• identification of plaque neovascularization;
• identification of the direction of plaque remodeling;
• detection of fibrous cap damage or risk of its occurrence.
Ultrasonography is the most available, the cheapest and non-
invasive method of examining arteries to identify and assess 
Fig. 1.  Atherosclerotic plaque: a schematic
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Types of atherosclerotic plaque
The echogenicity of atherosclerotic plaque mainly depends 
on lipids in its core and necrotic elements of the lipid core 
as well as on core microvascularization(15,19–21) and mineral-
ized or fibrous components.
In order to introduce uniform terminology regarding 
atherosclerotic plaque types, an ultrasound-based classi-
fication, called Gray-Weale–Nicolaides (GWN) classifica-
tion(22,23), has been introduced. It is based on the subjec-
tive image of plaque—its echogenicity—on B-Mode (2D) 
images. This classification distinguishes between five types 
(classes) of plaque, as described below.
Type (class) I: uniformly echolucent plaque
Plaque is almost entirely “translucent”. It is homogeneous, 
hypoechoic and composed mainly of lipid elements and 
necrotic structures (Fig. 3).
When imaging this type of plaque, attention must be paid 
to the presence and echogenicity of the fibrous cap. The 
hypoechoic structure of the plaque, similar to the echogenicity 
of fluid, is the primary difficulty. The level of echogenicity 
the morphology and condition of atherosclerotic plaque. 
Within the past 20 years, two-dimensional ultrasound (2D, 
B-Mode) and Doppler imaging have become the mainstay 
of assessment of pre-cranial carotid artery segments. These 
modalities enable the evaluation of both vascular morphol-
ogy and blood flow dynamics, including: flow direction, 
velocity, volume, laminar flow or pressure gradient. 
Ultrasonographic methods of atherosclerotic 
plaque evaluation
Atherosclerotic plaques can be examined using several 
ultrasound-based techniques, including: 
• real-time ultrasound (B-Mode, 2D Mode);
• Doppler ultrasound: color flow mode, power Doppler 
(in various configurations), including directional power 
Doppler, superb microvascular imaging; 
• non-Doppler flow evaluation methods (B-Flow);
• spatial (volumetric) ultrasound;
• contrast-enhanced ultrasound (CEUS);
• shear wave elastography (SWE).
The three last techniques (i.e. volumetric ultrasound, CEUS 
and elastography) will be discussed in the next parts of this 
publication series.
Fig. 3.  Uniformly echolucent plaque on the posterior wall of the LCCA (left common carotid artery). A. B-Mode. B. CFM mode. Author’s 
own material
A B
Fig. 2.  Atherosclerotic plaque evolution into vulnerable plaque (Virmani34)
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depends on the relationship between lipid–necrotic elements 
and fibrous structures of the plaque matrix.
The plaque border is visualized using Doppler imaging 
(Fig. 4 and Fig. 5) or non-Doppler methods (B-Flow), and 
the visualization depends on the image of blood flow in 
the vessel. The detection of a thin fibrous cap defines the 
plaque as TCAP (thin cap atheromatic plaque) and places 
it in the category of vulnerable plaques. It must be noted, 
however, that the fibrous cap with the thickness that 
defines it as TCAP is not visible on classical ultrasound, 
and its evaluation is highly subjective.
To sum up, type I plaques in the GWN classification are 
indistinguishable from fluid inside the vessel as seen on a 
B-Mode image due to their low echogenicity. They may be 
therefore overlooked in a diagnostic test. That is why most 
plaques are classified as type II plaques.
Type (class) II: predominately  
echolucent plaque
The plaque composition is as in type I with additional pres-
ence of single calcifications which perfectly aid in plaque 
imaging but prevent the precise visualization of the fibrous 
cap border due to reverberation at the calcification edges 
on a B-Mode image. The calcified part of the plaque should 
not exceed 25% of the plaque volume (in a volumetric 
examination) or 20–25% of the plaque size (in 2D assess-
ment) (Fig. 5, Fig. 6, Fig. 7).
Type (class) III: predominantly  
echogenic plaque
Plaque composition is as in type II with numerous calcifica-
tions constituting up to 50% of the plaque structure (Fig. 8).
Numerous reverberations at the calcification edges make 
the visualization of the borders and course of the fibrous 
cap extremely difficult on a B-Mode image. Plaque evalua-
tion and its potential classification as TCAP is dubious due 
to relatively numerous reverberations associated with the 
presence of mineralized components. 
In this group of plaques, flow imaging with Doppler or 
non-Doppler methods facilitates classification of plaque 
surface defects and enables visualization of potential irreg-
ularities and ulcerations. 
Type (class) IV: uniformly echogenic plaque
Plaque composition is as in type II with numerous calcifica-
tions constituting over 50% of the plaque structure (Fig. 9). 
Difficulties are similar to those in type III plaques with a 
significant increase in the number of reverberations.
Fig. 5.  Type (class) II plaque on the posterior wall of the CCA bifur-
cation. Author’s own material
Fig. 4.  Uniformly echolucent plaque on the posterior wall of the ICA (internal carotid artery). A. Plaque is visible thanks to flow visualiza-
tion in a directional power Doppler examination. B. Plaque visualized in a volumetric examination. Author’s own material
A B
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elements. Fibrous cap imaging in type V plaques is almost 
infeasible (Fig. 10).
The visualization of the arterial wall of pre-cranial 
arteries is an integral part of an ultrasound exami-
nation. This includes wall structure assessment with 
the measurement of the intima-media (IM) thickness, 
i.e. the total thickness of the tunica intima and tunica 
media. This measure is abbreviated as IMT. The IM 
complex is described(24) as a linear structure visible on 
both arterial walls (CCA, ICA, ECA) that can be imaged 
simultaneously in the longitudinal view. On ultrasound, 
it presents as a linear echogenic region that begins at 
the border of the vividly hypoechoic vascular lumen 
and reaches the hypoechoic linear area between the 
adventitia and tunica media. In physiological condi-
tions, the intima-media thickness ranges from 0.5 to 
0.9 mm(10,11,25) (Fig. 11).
The classification of plaques to type IV is difficult based on 
subjective assessment because of potential irregular distri-
bution of echogenic areas that prevent imaging.
Type (class) V: heavy calcification
In this case, the evaluation of echogenicity, which in prac-
tice means the number of calcifications, is impossible on 
B-Mode and Doppler imaging. 
Any attempts to assess plaque surface in this type of plaque 
are feasible only with specialized techniques: STIC B-Flow 
(spatiotemporal image correlation using the B-Flow tech-
nique) (Fig. 10 B), CEUS (Fig. 10 C) and possibly also intra-
vascular ultrasound (IVUS) as well as volumetric ultra-
sound. Numerous reverberations prohibit plaque structure 
assessment and evaluation of the borders of its individual 
Fig. 6.  Atherosclerotic plaque on the ICA anterior wall. A. Type II plaque, TCAP with elements of JBA (juxtaluminal black area) – blue 
arrow, and calcification – red arrow. B. Plaque visualized in a volumetric examination. Author’s own material
A B
A B
Fig. 7.  Mixed type II plaque. A. On the posterior wall of the CCA bifurcation, CFM image. B. On the ICA posterior wall – SMI (superb mi-
crovascular imaging). Author’s own material
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IMT is assessed by taking measurements in strictly speci-
fied points in individual arteries and then by calculating 
the average value (in proximal, medial and distal segments 
of the CCA and ICA and in the CCA bifurcation as well as, if 
needed, in the ECA and, when high-end ultrasound equip-
ment is available, also in the vertebral artery). Alternatively, 
IMT can be calculated in the examined segment of the 
artery using an IMT-dedicated tool integrated with the 
ultrasound calculation software (Fig. 12 A).
In normal conditions, when there is no atherosclerotic 
plaque, the arterial wall is clearly visible on a 2D (B-Mode) 
examination. 
Fig. 8.  Heterogeneous type III plaque. Authors’ own material
Fig. 9.  Type IV plaque; ICA flow with visible contrast enhancement. 
Authors’ own material
Fig. 10.  Completely calcified plaque. A. Acoustic shadow covers the 
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significantly increased was the change described as ath-
erosclerotic plaque.
In the 1970s, a relationship was found between the pres-
ence of defects on the surface of atherosclerotic plaque 
(irregularities, fissures, ulcerations) and CVAs (Clark, 
Koch, Constantinides)(28,29). It was concluded that the 
presence of changes (irregularity or ulceration) on the 
plaque surface indicates potential plaque instability and 
its greater susceptibility to damage (vulnerable plaque)(30). 
It was also stated that the presence of ulceration on the 
In multicenter ECST (European Carotid Surgery Trial) 
and NASCET (North American Symptomatic Carotid 
Endarerectomy Trial) trials(7), whose goal was to estab-
lish the eligibility of patients to endarterectomy (the cri-
terion of plaque stability was not taken into account in 
these trials), the fundamental parameters defining the 
atherosclerotic plaque were, next to IMT: the direction 
of plaque modeling and the total plaque size expressed 
as VWT (vessel wall thickness). This parameter is used 
to monitor treatment effects and assess the size of ath-
erosclerotic plaque. It is also used when IMT is over 
2 mm(26) (Fig. 11 B).
The term VWT(7,27) was first used in studies on atheroscle-
rotic plaques at the time when a vessel was considered a 
rigid “pipe,” where flow was evaluated as only a physical 
image of fluid rheological changes with no consideration 
devoted to dynamic changes in the walls of the described 
“pipe” and without taking into account any oscillation 
disorders or laminar flow. The wall thickness was the 
only parameter measured, and only when the value was 






Fig. 12.  Plaque ulceration. A. CFM image. B. SMI. C. Volumetric 
examination – surface rendering. Authors’ own material
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plaque surface is linked with the development of necrotic 
changes in the plaque lipid core that cause deformity 
and damage of the fibrous cap, which in turn leads to 
the transformation of stable plaque into vulnerable 
plaque(31).
In most of the available literature, authors mention diffi-
culties linked with adequate assessment of defects on the 
surface of vascular endothelium (continuity defects). They 
prohibits the visualization of laminar blood flow directly 
adjacent to plaque structures. Laminar flow disorders 
cause thrombocyte adhesion at the site of the endothelial 
defect, thus initiating a cascade of pathologies leading to 
CVA.
In accordance with contemporary statements(32–35), plaque 
surface irregularity should be distinguished from its ulcer-
ation. Ulceration is defined as a defect on the plaque sur-
face measuring at least 2×2 mm and reaching the near-
est visible IM complex. Smaller defects should be treated 
as irregularities, which are changes of lower clinical 
relevance.
Ulceration, i.e. plaque erosion, is described as an “acute,” 
abruptly developing thrombus, found directly adjacent 
to the intima media in the vessel wall with no endothe-
lium(16,18,36) (Fig. 12).
On ultrasound, this form of lesion presents as a 
hypoechoic intrusion on the plaque surface; its echo-
genicity depends on the size of the “fresh” thrombotic 
component. With thrombocytes being predominant, 
this component appears clearly hypoechoic. The image 
becomes slightly less hypoechoic when there are more 
collagen fibers making up the clot matrix; it may even 
appear iso-/normoechogenic in relation to the remain-
ing plaque structures. The image can be echogenic when 
fibrous elements prevail. This structure is defined by some 
authors(19,37,38) as JBA (juxtaluminal black area) or JHA 
(juxtaluminal hypoechoic area) (Fig. 7)(39,40).
As for ulceration, its atypical position in relation to 
atherosclerotic plaque, usually at the margin of the 
plaque, and the presence of marginal calcification at 
the edges of ulceration, are characteristic features(41–43) 
(Fig. 13).
Plaque ulceration is a much more frequent cause of 
thrombi than plaque rupture (74% of cases: ulcer-
ation and its complications; 40% of cases: rupture and 
its complications)(11). Attention must be paid to the 
fact that plaque ulceration and its complications are 
considered a cause of approximately 20% of sudden 
deaths from cerebrovascular accidents and cardiovas-
cular events. 
The ultrasound appearance of plaque surface (irregular-
ity or ulceration) helps identify its instability. This way, it 
supplements the description of plaque echogenicity in the 
Gray-Weale–Nicolaides classification, and is described with 
letters as:
Fig. 13.  Atherosclerotic plaque with smooth surface GWN IIIa. 
Authors’ own material
Fig. 14.  Atherosclerotic plaque with irregular surface GWN IIIb. 
Authors’ own material
Fig. 15.  Atherosclerotic plaque with ulceration GWN IIIc. Authors’ 
own material
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measurement of the plaque with the calculation of mean 
percentage values regarding the size of echogenic zones 
that correspond with plaque containing a greater number 
of fibrous or calcified structures.
Moreover, other ultrasound-based plaque classifica-
tions are appearing, taking into account both individual 
images of the plaque surface and plaque echogenicity. 
However, they are all derived from the original GWN 
classification(44).
The subjective assessment (visual scoring) should there-
fore be supplemented with the grey-scale median (GSM) 
evaluation, representing median tonal distribution of pixels 
in a scale from 0 (black) to 255 (white). On ultrasound, 
fluid (blood) corresponds with the lowest values, ranging 
from 0 to 5 in the GSM, while the highest values, from 
180 to 200 in the GSM, represent solid tissues (adventi-
tia)(18,24,45). Assigning the values to the observed parts of 
the plaque should be performed using as broad region of 
interest (ROI) as possible, i.e. the largest possible region 
encompassing the examined structure as allowed by the 
transducer. 
Attention should be paid to the need for further, multi-
directional diagnosis of atherosclerotic plaque in high-
risk patients, including volumetric (spatial) imaging 
examinations(8,11,20), contrast-enhanced ultrasound(14,46–49) 
(Fig. 17) or strain and shear wave elastography(50,51) 
(Fig. 18).
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• A – smooth plaque (Fig. 13);
• B – irregular plaque (Fig. 14);
• C – ulcerated plaque (Fig. 15).
For instance, the plaque from Fig. 16 with calcification of 
over 50% of the plaque volume and with the irregular sur-
face should be described as type IIIb plaque in the Gray-
Weale–Nikolaides classification.
Conclusion
Irrespective of the ultrasound technique employed, proper 
morphological evaluation of atherosclerotic plaque by 
means of subjective observation of echogenicity with clas-
sification to Gray-Weale–Nicolaides types as well as assess-
ment of the integrity of plaque surface, makes it possible to 
roughly evaluate plaque morphology and thereby its stability.
The contemporary techniques make this classification 
more objective. Computer software enables assessment and 
Fig. 16.  Type IIIb plaque in the Gray-Weale–Nikolaides classifica-
tion. Authors’ own material
Fig. 17.  Atherosclerotic plaque, CEUS. Authors’ own material
Fig. 18.  Atherosclerotic plaque, SWE. Authors’ own material
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